Waters Corporation
General ticker "WAT" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $22.6B
Waters Corporation follows the US Stock Market performance with the rate: 46.5%.
Estimated limits based on current volatility of 1.7%: low 356.89$, high 369.08$
Factors to consider:
- Company included in S&P500 list
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [302.13$, 423.17$]
- 2024-12-30 to 2025-12-30 estimated range: [344.55$, 475.41$]
Financial Metrics affecting the WAT estimates:
- Positive: Non-GAAP EPS, $ of 11.75 > 2.29
- Negative: Investing cash flow per share, $ of -24.41 <= -3.48
- Negative: Interest expense per share, $ of 1.67 > 0.74
- Negative: Industry operating cash flow per share per price (median), % of 0.50 <= 3.85
- Positive: Return on assets ratio (scaled to [-100,100]) of 12.19 > 7.10
- Negative: Industry inventory ratio change (median), % of 1.54 > 0.49
Short-term WAT quotes
Long-term WAT plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $2,780.71MM | $2,971.96MM | $2,956.42MM |
| Operating Expenses | $1,959.00MM | $2,098.56MM | $2,138.74MM |
| Operating Income | $821.71MM | $873.39MM | $817.68MM |
| Non-Operating Income | $-15.51MM | $-35.55MM | $-81.43MM |
| Interest Expense | $32.72MM | $37.78MM | $98.86MM |
| R&D Expense | $168.36MM | $176.19MM | $174.94MM |
| Income(Loss) | $806.19MM | $837.85MM | $736.24MM |
| Taxes | $113.35MM | $130.09MM | $94.01MM |
| Profit(Loss) | $692.84MM | $707.75MM | $642.23MM |
| Stockholders Equity | $367.55MM | $504.49MM | $1,150.34MM |
| Inventory | $356.10MM | $455.71MM | $516.24MM |
| Assets | $3,094.93MM | $3,281.45MM | $4,626.85MM |
| Operating Cash Flow | $747.27MM | $611.66MM | $602.81MM |
| Capital expenditure | $168.27MM | $183.46MM | $160.63MM |
| Investing Cash Flow | $-231.63MM | $-107.97MM | $-1,442.27MM |
| Financing Cash Flow | $-438.27MM | $-509.63MM | $754.95MM |
| Earnings Per Share* | $11.25 | $11.80 | $10.87 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.